Learn More
Description
Specifications
Specifications
| Antigen | TACI/TNFRSF13B/CVID |
| Applications | Immunohistochemistry, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 1.0 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 0.5-2 ug/ml, Immunohistochemistry reported in multiple pieces of scientific literature, Immunohistochemistry-Paraffin reported in scientific literature (PMID 22512719) |
| Formulation | PBS with 0.05% Sodium Azide |
| Gene Accession No. | NP_036584 |
| Gene Alias | CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B |
| Gene Symbols | TNFRSF13B |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
